• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 17 Mar

    Timber Pharmaceuticals Development Partner, AFT Pharmaceuticals, Enters into Licensing Agreement for Pascomer (TMB-002) in Europe

    - Extension of agreement with AFT Pharmaceuticals grants Desitin Arzneimittel GmbH exclusive license and supply rights for TMB-002 in Europe - Basking Ridge, NJ - (NewMediaWire) - March 17, 2021 - Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization… Read More..

    Share this:
  • 16 Mar

    Soligenix Anticipated to Achieve Multiple Milestones in 2021

    New York, New York--(Newsfile Corp. - March 16, 2021) - PCG Digital -- The future is looking bright at Soligenix, Inc. In a corporate update released on February 24th, Dr. Christopher Schaber, Chairman, President and CEO, updated investors on the status of ongoing research projects. The report suggests that multiple… Read More..

    Share this:
  • 16 Mar

    Why Hidden Value Stock Bubblr Is on a Mission to Fix the Internet

    Bubblr, an ethical technology company that was recently granted a patent for a new internet-based search mechanism, intends to change that. CEO Steven Saunders explained in a recent video how the company used "first principle thinking" to develop the new technology. "Our founders identified the fundamental pillars that hold up… Read More..

    Share this:
« Previous 1 … 96 97 98 99 100 … 295 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact